Organization
Lobe Sciences
1 clinical trial
Clinical trial
Phase 1, Open-Label, One-Treatment, Single-Dose, One-Period, Pharmacokinetic Study of Psilocin 4 mg as Its Mucic Acid Salt (L-130) Form, in Healthy Subjects Under Fasted ConditionsStatus: Completed, Estimated PCD: 2023-07-30